Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Bio-Medical Materials and Engineering|September 3, 2019
Multiple platelet-rich plasma preparations can solubilize freeze-dried chitosan formulations to form injectable implants for orthopedic indicationsLeili Ghazi Zadeh, Anik Chevrier, Martin Lamontagne, et al.Pharmaceuticals (Basel, Switzerland)|June 27, 2024
Emerging Perspectives on Prime Editor Delivery to the BrainEli BenDavid, Sina Ramezanian, Yaoyao Lu, et al.Biomaterials|April 1, 2011
Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexesMarc Thibault, Mélina Astolfi, Nicolas Tran-Khanh, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|July 3, 2025
Chitosan/Platelet-Rich Plasma Implants in an Ovine Arthroscopic Model of Meniscus RepairMargaux Delvaux, Anik Chevrier, Sotcheadt Sim, et al.International Journal of Nanomedicine|March 30, 2012
Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide deliveryMohamad Alameh, Diogo Dejesus, Myriam Jean, et al.Biomaterials|March 25, 2017
Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophagesDavid Fong, Pascal Grégoire-Gélinas, Alexandre P Cheng, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 17, 2011
Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetesMyriam Jean, Mohamad Alameh, Diogo De Jesus, et al.Biomacromolecules|December 7, 2017
siRNA Delivery with Chitosan: Influence of Chitosan Molecular Weight, Degree of Deacetylation, and Amine to Phosphate Ratio on in Vitro Silencing Efficiency, Hemocompatibility, Biodistribution, and in Vivo EfficacyMohamad Alameh, Marc Lavertu, Nicolas Tran-Khanh, et al.Vaccines|August 28, 2025
Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological EfficacyMajed Ghattas, Garima Dwivedi, Anik Chevrier, et al.ACS Applied Bio Materials|December 18, 2023
Chlorophyllin-Containing Copolymers and Their Responsive PropertiesXuemin Liu, Guillaume Beaudoin, Hu Zhang, et al.Pageof 5